Exari Licenses/Coupa

The contract involves the procurement of licenses to facilitate communication and the development and maintenance of review templates, such as approval letters and complete response letters. This acquisition supports the Food and Drug Administration (FDA) under the NAICS code 541519, which pertains to other computer related services. The focus is on securing software licenses, specifically related to "Exari Licenses/Coupa," to assist in streamlining the creation and management of essential regulatory documents. The contract is currently listed as a forecast with no specified solicitation number or designated set-aside type. While detailed location information for performance and agency contact points remain unspecified, inquiries can be directed to the FDA’s Cder Acquisition Liaison via the provided email. The contracting officer's details are yet to be determined. This procurement aligns with the FDA's commitment to enhancing regulatory processes through efficient document template technology.